Human Recombinant RANKL, STEMCELL Technologies (CAT#: STEM-CT-0947-ZJF)

Receptor activator of nuclear factor kappa-B ligand (RANKL) is a member of the tumor necrosis factor (TNF) superfamily (Anderson et al.). Cytokines in the TNF superfamily are involved in a variety of long-term cellular activities such as differentiation, proliferation, and cell death (MacEwan). RANKL is a type II homotrimeric transmembrane protein expressed in both a membrane-bound and secreted form (Ikeda et al.). RANKL binds to the receptor activator of nuclear factor kappa-B (RANK). Upon binding to its receptor, RANKL activates the AKT signaling pathway (Moon et al.). Osteoprotegerin (OPG) may also bind RANKL, and this binding competes with RANKL-RANK binding (Lacey et al.). RANKL is involved in osteoclastogenesis (Lacey et al.; Yasuda et al.) and T cell activation (Wong et al.).

Subtype: Cytokines
Cell Type: Airway Cells, Cancer Cells and Cell Lines, Dendritic Cells, Intestinal Cells, Mammary Cells, Osteoblasts, Other, Pancreatic Cells, Prostate Cells, T Cells
Species: Human
Area of Interest: Cancer, Stem Cell Biology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant Prolactin, STEMCELL Technologies
Human Recombinant R-Spondin-1, STEMCELL Technologies
Human Recombinant RANKL, ACF, STEMCELL Technologies
Human Recombinant RANTES (CCL5), STEMCELL Technologies